Northern Trust
IBIO icon

Northern Trust’s iBio IBIO Stock Holding History

Northern Trust’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Buy
77,324
+37,010
+92% +$85.9K ﹤0.01% 4024
2025
Q4 		$77.8K Buy
40,314
+17,270
+75% +$23.6K ﹤0.01% 4187
2025
Q3 		$19.1K Hold
23,044
– – ﹤0.01% 4378
2025
Q2 		$17.6K Hold
23,044
– – ﹤0.01% 4346
2025
Q1 		$92.6K Buy
23,044
+12,879
+127% +$50.1K ﹤0.01% 4131
2024
Q4 		$24.9K Hold
10,165
– – ﹤0.01% 4358
2024
Q3 		$22.6K Hold
10,165
– – ﹤0.01% 4324
2024
Q2 		$21.4K Buy
+10,165
New +$21.9K ﹤0.01% 4325
2023
Q4 		– Sell
-888
Closed -$5.39K – 4501
2023
Q3 		$5.39K Hold
888
– – ﹤0.01% 4432
2023
Q2 		$10.8K Hold
888
– – ﹤0.01% 4469
2023
Q1 		$36.9K Buy
888
+144
+19% +$3.71K ﹤0.01% 4330
2022
Q4 		$6.61K Hold
744
– – ﹤0.01% 4611
2022
Q3 		$63K Hold
744
– – ﹤0.01% 4262
2022
Q2 		$98K Sell
744
-2,830
-79% -$425K ﹤0.01% 4175
2022
Q1 		$765K Sell
3,574
-230
-6% -$48.1K ﹤0.01% 3553
2021
Q4 		$1.04M Sell
3,804
-72
-2% -$27.5K ﹤0.01% 3522
2021
Q3 		$2.05M Sell
3,876
-129
-3% -$80.3K ﹤0.01% 3276
2021
Q2 		$3.02M Sell
4,005
-373
-9% -$272K ﹤0.01% 3151
2021
Q1 		$3.37M Buy
4,378
+469
+12% +$409K ﹤0.01% 2983
2020
Q4 		$2.05M Buy
3,909
+2,160
+123% +$1.76M ﹤0.01% 3181
2020
Q3 		$1.77M Buy
1,749
+353
+25% +$512K ﹤0.01% 3119
2020
Q2 		$1.55M Buy
1,396
+1,266
+974% +$828K ﹤0.01% 3175
2020
Q1 		$69K Buy
130
+101
+348% +$38.9K ﹤0.01% 3889
2019
Q4 		$4K Hold
29
– – ﹤0.01% 4229
2019
Q3 		$8K Hold
29
– – ﹤0.01% 4198
2019
Q2 		$10K Hold
29
– – ﹤0.01% 4206
2019
Q1 		$13K Hold
29
– – ﹤0.01% 4155
2018
Q4 		$11K Hold
29
– – ﹤0.01% 4192
2018
Q3 		$12K Hold
29
– – ﹤0.01% 4242
2018
Q2 		$13K Buy
29
+15
+107% +$11.3K ﹤0.01% 4240
2018
Q1 		$15K Hold
14
– – ﹤0.01% 4185
2017
Q4 		$12K Hold
14
– – ﹤0.01% 4186
2017
Q3 		$22K Hold
14
– – ﹤0.01% 4147
2017
Q2 		$27K Hold
14
– – ﹤0.01% 4155
2017
Q1 		$30K Hold
14
– – ﹤0.01% 4112
2016
Q4 		$27K Buy
14
+1
+8% +$2.33K ﹤0.01% 4080
2016
Q3 		$36K Hold
13
– – ﹤0.01% 4049
2016
Q2 		$47K Hold
13
– – ﹤0.01% 4022
2016
Q1 		$37K Hold
13
– – ﹤0.01% 4062
2015
Q4 		$37K Hold
13
– – ﹤0.01% 4098
2015
Q3 		$44K Sell
13
-3
-19% -$11.1K ﹤0.01% 4094
2015
Q2 		$75K Sell
16
-4
-20% -$18.6K ﹤0.01% 3998
2015
Q1 		$79K Buy
20
+12
+150% +$40.7K ﹤0.01% 4083
2014
Q4 		$27K Hold
8
– – ﹤0.01% 4161
2014
Q3 		$24K Hold
8
– – ﹤0.01% 4202
2014
Q2 		$16K Hold
8
– – ﹤0.01% 4189
2014
Q1 		$20K Buy
8
+2
+33% +$5.34K ﹤0.01% 4114
2013
Q4 		$9K Hold
6
– – ﹤0.01% 4057
2013
Q3 		$12K Hold
6
– – ﹤0.01% 4016
2013
Q2 		$12K Buy
+6
New +$13.8K ﹤0.01% 4028

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Northern Trust's IBIO Position: Q1 2026 in Review

Northern Trust increased its iBio (IBIO) stake by 92% in Q1 2026, buying an estimated $85.9K and bringing the position to 77,324 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #4024.

Northern Trust first reported a position in IBIO in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.37M in Q1 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Northern Trust held 77,324 shares of iBio worth $147K as of Q1 2026.
  • Northern Trust bought 37,010 iBio shares in Q1 2026, an estimated $85.9K.
  • iBio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4024 holding.
  • Northern Trust first reported a position in iBio in Q2 2013 and has held it in 50 quarters since.
  • Northern Trust's iBio position peaked at $3.37M in Q1 2021.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.